Federal Data HubHRSA 340B · JSON

CARDEZA FOUNDATION HEMOPHILIA CENTER

THOMAS JEFFERSON UNIVERSITY HOSPITAL · 340B ID HM1270

Not participatingHemophilia Treatment Center

CARDEZA FOUNDATION HEMOPHILIA CENTER is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in PHILADELPHIA, PA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 9 contract-pharmacy arrangement(s) (0 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (9)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCWARRENDALE, PA2016-07-012022-01-0123041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2016-07-012017-11-0145979
ACCREDO HEALTH GROUP INCNASHVILLE, TN2016-07-012017-11-015878
ACCREDO HEALTH GROUP, INC.NEWARK, DE2016-07-012017-11-0198337
ACCREDO HEALTH GROUP, INC.ORLANDO, FL2016-07-012017-11-0139194
ACCREDO HEALTH GROUP, INC.INDIANAPOLIS, IN2016-07-012017-11-0151763
ACCREDO HEALTH GROUP, INC.LENEXA, KS2018-01-012022-01-0162883
ACCREDO HEALTH GROUP, INC.PINE BROOK, NJ2018-01-012022-01-0116515
WALNUT HOME THERAPEUTICSKING OF PRUSSIA, PA2008-07-072022-01-01747

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.